Hannu Haapasalo
Hannu Haapasalo
Unknown affiliation
Verified email at fimlab.fi
Title
Cited by
Cited by
Year
Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques
SL Sallinen, PK Sallinen, HK Haapasalo, HJ Helin, PT Helén, P Schraml, ...
Cancer research 60 (23), 6617-6622, 2000
4732000
Medulloblastoma
F Giangaspero
Pathology and genetics of tumors of the nervous system, 2000
3142000
Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia.
A Ranki, M Nyberg, V Ovod, M Haltia, I Elovaara, R Raininko, ...
AIDS (London, England) 9 (9), 1001-1008, 1995
3071995
Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age
E Kok, S Haikonen, T Luoto, H Huhtala, S Goebeler, H Haapasalo, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
2552009
Incidence of gliomas by anatomic location
S Larjavaara, R Mäntylä, T Salminen, H Haapasalo, J Raitanen, ...
Neuro-oncology 9 (3), 319-325, 2007
2532007
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, ...
The Journal of clinical investigation 123 (2), 2013
1932013
Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation
H Miettinen, J Kononen, H Haapasalo, P Helén, P Sallinen, ...
Cancer research 55 (12), 2691-2695, 1995
1861995
Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samples
PK Sallinen, HK Haapasalo, T Visakorpi, PT Helén, IS Rantala, JJ Isola, ...
The Journal of pathology 174 (4), 275-282, 1994
1851994
ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease
RJ Gilbertson, L Bentley, R Hernan, TT Junttila, AJ Frank, H Haapasalo, ...
Clinical Cancer Research 8 (10), 3054-3064, 2002
1812002
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2
A Vihola, G Bassez, G Meola, S Zhang, H Haapasalo, A Paetau, ...
Neurology 60 (11), 1854-1857, 2003
1782003
Volume corrected mitotic index (M/V-INDEX): The standard of mitotic activity in neoplasms
H Haapasalo, E Pesonen, Y Collan
Pathology-Research and Practice 185 (5), 551-554, 1989
1401989
Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis
JA Haapasalo, KM Nordfors, M Hilvo, IJ Rantala, Y Soini, AK Parkkila, ...
Clinical Cancer Research 12 (2), 473-477, 2006
1332006
Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression
K Korhonen, T Salminen, J Raitanen, A Auvinen, J Isola, H Haapasalo
Journal of neuro-oncology 80 (1), 1-7, 2006
1262006
Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
SM Siitonen, HK Haapasalo, IS Rantala, HJ Helin, JJ Isola
Modern pathology: an official journal of the United States and Canadian …, 1995
1121995
Delayed MR imaging changes in acute disseminated encephalomyelitis
J Honkaniemi, P Dastidar, V Kähärä, H Haapasalo
American journal of neuroradiology 22 (6), 1117-1124, 2001
1022001
Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
H Haapasalo, J Isola, P Sallinen, H Kalimo, H Helin, I Rantala
The American journal of pathology 142 (5), 1347, 1993
1001993
Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours
P Hynninen, L Vaskivuo, J Saarnio, H Haapasalo, J Kivelä, S Pastorekova, ...
Histopathology 49 (6), 594-602, 2006
962006
XRCC1 and XRCC3 variants and risk of glioma and meningioma
A Kiuru, C Lindholm, S Heinävaara, T Ilus, P Jokinen, H Haapasalo, ...
Journal of neuro-oncology 88 (2), 135-142, 2008
932008
PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A–mediated inactivation in human malignant glioma
P Puustinen, MR Junttila, S Vanhatupa, AA Sablina, ME Hector, ...
Cancer research 69 (7), 2870-2877, 2009
902009
Prognosis of ovarian carcinomas: prediction by histoquantitative methods
H Haapasalo, Y Collan, NB Atkin, E Pesonen, A Seppä
Histopathology 15 (2), 167-178, 1989
901989
The system can't perform the operation now. Try again later.
Articles 1–20